VK

Vijay Krishan

Active Director Director DIN 08122073
DIN 08122073 First appointment May 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2018
Shareholding value •••• Premium profile

About Vijay Krishan

Data last updated:

Vijay Krishan is a Director at Toronto Pharmaceuticals Private Limited (since 2018). The company operates in Pharma. Toronto Pharmaceuticals Private Limited reported revenue of ₹82 Lakh (FY 2025).

DIN 08122073
Primary Designation Director
Industry Pharma
First Appointment 02 May 2018
Oldest Company Age 20 yrs
Largest company Toronto Pharmaceuticals Private Limited · ₹82 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 May 20182006₹82 Lakh (FY 2025)Active

Board colleagues of Vijay Krishan

Directorship timeline

Open interactive timeline →
Toronto Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vijay Krishan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijay Krishan

Vijay Krishan currently holds 1 directorship: Toronto Pharmaceuticals Private Limited (Director, since 02 May 2018, revenue ₹82 Lakh (FY 2025)).

Vijay Krishan was first appointed on 02 May 2018 as Director at Toronto Pharmaceuticals Private Limited.

The current boards of Vijay Krishan's companies include Archit Mittal (Toronto Pharmaceuticals Private Limited), Bharat Bhushan Mittal (Toronto Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available